The following information was sent to me by a professional Monitor of Clinical Trials, on June 12, 2009:

“Of course today, Novartis announces that they have the Swine Flu vaccine. Look at the dates”



The article above states that “WHO says drugmakers will likely have vaccines approved and ready for sale after September.”

Four months?  From June to September? To do animal safety testing, then human safety and efficacy testing?

No way – that should take “about 8 to 10 months” according to Rangappa Ramachandra, program director and lead scientist of immunology services at Covance.

Four months to discover, test and manufacture a novel vaccine would be a little fishy, even under the best of circumstances.

Note above that Novartis’ “vaccine was made in cells, rather than grown in eggs as is usually the case with vaccines”.

Really? A whole new process? Weeks ahead of expectation? According to UPI:

Currently, influenza vaccines licensed by the Food and Drug Administration are made in specialized chicken eggs using a process that has changed little over the past five decades.
In place of eggs, cell-based vaccine production uses laboratory-grown cells that are capable of hosting a growing virus.”

Really! What kind of cells would those be? Canine! Doggie!!

So, let’s get this straight: Novartis injects a virus into puppy kidney cells, “where it multiplies. The cells’ outer walls are then removed, harvested, purified, and inactivated.”

And then injected into you. And your kids.

Wow, don’t see any way that could go wrong, do you?

I mean, they’d test it out really – REALLY – intensely, right?

That’s the law, right? In accordance with the Food and Drug Administration’s own rules regarding the testing of drugs for human use, right?

Part 21 of the Code of Federal Regulations, RIGHT???

Especially since this is a new, previously untested vaccine, made via a brand new technology – right? They’d test it really well…RIGHT???


Again – from my Clinical Trials Monitoring source:

“Check the FDA’s announcement of Emergency Use of flu vaccines. Specifically for those under 1 year of age…”


Note the appearance of the words “unapproved” and “uncleared” in the FDA’s news release?

Our Clinical Trials Monitor friend sure did:

“…and Bush’s power to DHHS with Project Bioshield. No one can sue pharmaceutical companies for vaccination injuries”

“The Biodefense and Pandemic Vaccine and Drug Development Act of 2005 (S. 1873), nicknamed “Bioshield Two” aims to shortcut safety testing for new vaccines and drugs in case of a pandemic, and to protect vaccine makers and the pharmaceutical industry from legal liability for vaccine injuries.”

How nicely everything has been put together.


Yeah, it is remarkable.

Now, let’s see…FDA releases the Medical Industry from responsibility for using “unapproved” and “uncleared” products.

Bioshield releases the Pharma companies from any legal responsibility if people start to die.

Wow! And since “Novartis said more than 30 governments have requested vaccine supplies, including the U.S. Department of Health and Human Service, which placed a $289 million order in May”, we can all bet there’s going to be lots of money made.

Especially if mean old Mr. H1N1 forces the poor government to enact some kind of mandatory vaccination program.

Remarkable indeed.